|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 6-K filed Mar 30, 2009. Research,
Development & Commercial Activities
We have developed clear and accountable policies and procedures
for all our medical and scientific practices to ensure
comprehensive oversight of all our clinical, scientific,
pharmacovigilance and medical governance issues is achieved.
We take seriously our ethical and scientific responsibilities
and demonstrate these aspects of our work in our relationships
with our clinical partners; in this work we have regard of
anti-kickback statutes, which prohibit offering payment to
induce the purchasing of our products, as well as false claims
legislation. In addition, we aim to apply the highest standards
in all our clinical and scientific research in every country in
which we operate and with every group of stakeholders with whom
we interact.
All our clinical trials are conducted according to the Good
Clinical Practice guidelines developed by the
International Conference on Harmonisation and the
principles contained in the World Medical Association
Declaration of Helsinki on the Ethical Principles for
Medical Research Involving Human Subjects (2004).
|
| |||||||
